A clinical study of STP705 for the treatment of advanced cholangiocarcinoma (CCA)
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2019
Price : $35 *
At a glance
- Drugs STP 705 (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 29 Apr 2019 Planned initiation date changed to 1 Jul 2019.
- 26 Apr 2019 According to a Sirnaomics Oncology media release, the company expects to initiate this trial in the seond half of 2019.
- 04 Sep 2018 New trial record